NASDAQ:PTIE
Delisted
Pain Therapeutics Stock Company Profile
$40.17
+0 (+0%)
At Close: Aug 17, 2022
Information
7801 North Capital of Texas Highway
Austin TX 78731
512-501-2444
Industry: Biotechnology
Sector: Healthcare
Description
Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs in the United States. The companys lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. It also develops FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; and PTI-125, a small molecule drug candidate to treat Alzheimers disease and other neurological disorders. The company was founded in 1998 and is based in Austin, Texas.
